Your browser doesn't support javascript.
loading
Extensively drug resistant tuberculosis in Mali: a case report.
Diarra, Bassirou; Toloba, Yacouba; Konate, Bakary; Sanogo, Moumine; Togo, Antieme Combo Georges; Camara, Fatimata; Berthe, Gaoussou; Soumaré, Dianguina; Baya, Bocar; Goita, Drissa; Sarro, Yeya Dit Sadio; Maiga, Mamoudou; Belson, Michael; Orsega, Susan; Dao, Sounkalo; Murphy, Robert L; Siddiqui, Sophia; de Jong, Bouke C; Doumbia, Seydou; Diallo, Souleymane.
Afiliação
  • Diarra B; University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali. bdiarra@icermali.org.
  • Toloba Y; Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. bdiarra@icermali.org.
  • Konate B; Service de Pneumo-phtisiologie du Centre Hospitalier Universitaire du Point-G, Bamako, Mali.
  • Sanogo M; Programme National de Lutte Contre la Tuberculose (PNLT), Ministère de la Santé et de l'hygiène Publique, Bamako, Mali.
  • Togo ACG; University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Camara F; University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Berthe G; Laboratoire National de Référence des Mycobactéries (LNR), Institut National de Recherche en Santé Publique (INRSP), Bamako, Mali.
  • Soumaré D; Service de Pneumo-phtisiologie du Centre Hospitalier Universitaire du Point-G, Bamako, Mali.
  • Baya B; Service de Pneumo-phtisiologie du Centre Hospitalier Universitaire du Point-G, Bamako, Mali.
  • Goita D; University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Sarro YDS; University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Maiga M; University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Belson M; Global Health, Northwestern University, Chicago, IL, USA.
  • Orsega S; Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Dao S; Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Murphy RL; University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Siddiqui S; Global Health, Northwestern University, Chicago, IL, USA.
  • de Jong BC; Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Doumbia S; Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • Diallo S; University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
BMC Res Notes ; 10(1): 561, 2017 Nov 06.
Article em En | MEDLINE | ID: mdl-29110699
BACKGROUND: Drug resistant tuberculosis presents a major public health challenge. CASE PRESENTATION: We present here the first two patients diagnosed with extensively drug resistant tuberculosis in Bamako, Mali. Genotypic findings suggest possible nosocomial transmission from the first patient to the second one, resulting in superinfection of the second patient. After being diagnosed with extensively drug resistant tuberculosis in August 2016, the patients only started receiving appropriate treatment 10 months later. CONCLUSION: The identification of these patients highlights the need for improved diagnostic and treatment algorithms for better surveillance and management of drug resistance in Mali. In the interest of these as well as future patients suffering from resistant tuberculosis, all steps recommended for programmatic management of drug resistant tuberculosis must be urgently prioritized in order to strengthen the multidrug resistant tuberculosis program.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Extensivamente Resistente a Medicamentos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans / Middle aged País como assunto: Africa Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Extensivamente Resistente a Medicamentos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans / Middle aged País como assunto: Africa Idioma: En Ano de publicação: 2017 Tipo de documento: Article